Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sesen Bio
Sesen Bio
Sesen slams brakes on phase 3 bladder cancer program to save cash as it looks for off-ramp
Fierce Biotech
Mon, 07/18/22 - 07:15 pm
Sesen Bio
bladder cancer
clinical trials
Vicineum
Sesen’s corporate spin amounts to nothing
EP Vantage
Mon, 08/16/21 - 11:06 am
Sesen Bio
FDA
Vicineum
FDA rejects Sesen Bio's bladder cancer pitch, sending shares spiraling back to penny stock territory
Endpoints
Sun, 08/15/21 - 11:01 pm
Sesen Bio
FDA
Vicineum
bladder cancer
Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer
Pharmaceutical Business Review
Sat, 08/10/19 - 01:54 pm
Sesen Bio
clinical trials
Vicinium
bladder cancer
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sat, 05/11/19 - 12:31 pm
biotech
Achillion
Sesen Bio
The Medicines Company
Amgen
Daiichi Sankyo
earnings
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Mon, 12/31/18 - 11:57 am
Goldman Sachs
Portola Pharmaceuticals
AndexXa
Sesen Bio
Vicinium